More specifically, miR-372 can suppress p62, thus increasing ROS (reactive oxygen species) and motility in HNSCC cells by inhibiting phase II detoxification enzyme NADPH Quinone oxidoreductase 1 (NQO1) [98]. Here, NQO1 is linked to head and neck squamous cell carcinoma.